eCART vs Octagos
eCART, from AgileMD, scores adult hospitalized ward patients for death or ICU transfer, and its FDA record is K233253, decided in June 2024. Scoring starts once any vital sign is charted. Octagos triages transmissions from implanted cardiac devices, and openFDA lists no 510(k) under Octagos or Octagos Health. Hospital quality and rapid-response teams are eCART's customers. Electrophysiology practices and hospital device clinics are Octagos's. One watches ward vital signs and the other watches implanted devices, so the two purchases do not compete.
On EHR fit, Octagos's homepage names Epic with SMART on FHIR and SSO, Oracle Health, athenahealth, medent and NextGen. AgileMD's homepage says native EHR workflows and names no vendor. For pricing, AgileMD offers a demo request and Octagos's pricing page names tiers without amounts.
Decision support · Reviewed November 2, 2026
eCART
by AgileMD
Early warning software that scores hospitalized ward patients for risk of deterioration from EHR data, for use by trained clinicians.
Octagos
by Octagos
Remote cardiac device monitoring where AI triages implantable device transmissions and US specialists review them, for cardiology clinics.
When to pick each one
eCART
- FDA 510(k) K233253 for ward deterioration, June 2024
- Scores adult hospitalized ward patients for death or ICU transfer
- Vendor states SOC 2 and HIPAA
Octagos
- Names Epic, Oracle Health, athenahealth, medent, NextGen
- Remote monitoring of implanted cardiac device transmissions
- Usage-based or fixed-monthly billing options
Score
Each row shows points earned of points available under the published rubric.
eCART
56of 100
Octagos
43of 100
| Dimension | eCART | Octagos | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 0 / 12 | +12 |
| HIPAA / SOC2 / BAA | 10 / 10 | 10 / 10 | 0 |
| EHR integrations (count) | 0 / 5.6 | 2.8 / 5.6 | -2.8 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 4.8 / 4.8 | -4.8 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 21 / 21 | 14.7 / 21 | +6.3 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
eCART
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. There is no pricing page; the site offers a demo request only. |
Octagos
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
eCART
FDA decisions
K233253 (opens in new tab)510(k)2024-06-21
eCARTv5 Clinical Deterioration Suite (eCART)
Peer-reviewed
5 PubMed records name eCART.
- Early Warning Scores With and Without Artificial Intelligence. (opens in new tab)
- Multicenter Development and Prospective Validation of eCARTv5: A Gradient Boosted Machine Learning Early Warning Score. (opens in new tab)
- DETERIO-LLM: enhancing traditional deterioration risk scores with clinical context and advanced reasoning. (opens in new tab)
Octagos
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Peer-reviewed
2 PubMed records name Octagos.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | eCART | Octagos |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Epic, Oracle Health, athenahealth, medent, NextGen |
| Founded | n/a | n/a |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.